Dr Gary Nabel M.D., Ph.D.

Dr. Gary J. Nabel, M.D., Ph.D. is Senior Vice President, Chief Scientific Officer and Deputy to the President for Global R&D at Sanofi, Cambridge, Massachusetts. He is responsible for assessing and coordinating Sanofi's scientific direction for biopharmaceuticals, vaccines and animal health with a focus on improving translational approaches across Sanofi. In his role, he leads the evaluation of scientific quality of projects and programs across all of R&D, and participates in setting Sanofi's overall strategy.

Before joining Sanofi, he served at the National Institutes of Health, where he was Director of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases since 1999. During his tenure at the NIH, Dr. Nabel provided overall direction and scientific leadership of the basic, clinical, and translational research activities of the VRC and guides development of novel vaccine strategies against HIV and other emerging and re-emerging infectious diseases, including Ebola/Marburg hemorrhagic fevers, influenza, chikungunya and other viruses.

Dr. Nabel graduated magna cum laude from Harvard College in 1975 and continued his graduate studies at Harvard, completing his Ph.D. in 1980 and his M.D. two years later. He then served as a postdoctoral fellow in the laboratory of David Baltimore at MIT’s Whitehead Institute. Before his appointment at the VRC, Dr. Nabel served as the Henry Sewall Professor of Internal Medicine, professor of Biochemistry, and Howard Hughes Medical Institute investigator at the University of Michigan in Ann Arbor. In addition to his faculty positions, Dr. Nabel also served as the Director of the Center for Gene Therapy and co-director of the Center for Molecular Medicine at the University of Michigan.

In recognition of his expertise at the forefront of virology, immunology, gene therapy, and molecular biology, Dr. Nabel was elected as a member of the Institute of Medicine of the National Academy of Sciences in 1998, where he still serves. Among his many other honors, Dr. Nabel has received the Amgen Scientific Achievement Award from the American Society for Biochemistry and Molecular Biology, the Health and Human Services Secretary’s Award for Distinguished Service in 2003, and election to the American Association of Physicians and the American Association for Advancement of Science.